Literature DB >> 1484564

5-Hydroxytryptamine-induced increase in left ventricular dP/dtmax does not suggest the presence of ventricular 5-HT4 receptors in the pig.

P R Saxena1, C M Villalón, K M Dhasmana, P D Verdouw.   

Abstract

Although 5-hydroxytryptamine (5-HT) increases porcine atrial force and rate via 5-HT4 receptors, its effect on left ventricular contractility is not known. Therefore, using the maximum rate of rise of left ventricular pressure (LVdP/dtmax) as an index of cardiac contractility, we have attempted to analyze the possible role of ventricular 5-HT4 receptors in the anaesthetized pig. The full agonists at 5-HT4 receptors, 5-HT and 5-methoxytryptamine (each 3, 10 and 30 micrograms.kg-1), and the beta-adrenoceptor agonist, isoprenaline (0.01, 0.03 and 0.1 micrograms.kg-1), increased heart rate, LVdP/dtmax and cardiac output. For a given degree of tachycardia, the increase in LVdP/dtmax by isoprenaline was substantially more than that observed with either 5-HT or 5-methoxytryptamine. The 5-HT4 receptor partial agonist, renzapride (3, 10, 30, 100 and 300 micrograms.kg-1), also increased heart rate and LVdP/dtmax dose-dependently. When the heart was paced at 150 beats.min-1, increases in LVdP/dtmax as well as cardiac output (except with the highest doses) by 5-HT, 5-methoxytryptamine and isoprenaline were clearly attenuated. However, the magnitude of attenuation of LVdP/dtmax responses by cardiac pacing was more marked in the case of 5-HT and 5-methoxytryptamine than with isoprenaline. The effects of renzapride (300 micrograms.kg-1) and tropisetron (0.3 and 3 mg.kg-1) on increases in heart rate and LVdP/dtmax by 5-HT, 5-methoxytryptamine and isoprenaline were also studied.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1484564     DOI: 10.1007/bf00168735

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

Review 1.  5-Hydroxytryptamine: a chameleon in the heart.

Authors:  P R Saxena; C M Villalón
Journal:  Trends Pharmacol Sci       Date:  1991-06       Impact factor: 14.819

Review 2.  Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.

Authors:  O E Brodde
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930.

Authors:  A Dumuis; R Bouhelal; M Sebben; J Bockaert
Journal:  Eur J Pharmacol       Date:  1988-01-27       Impact factor: 4.432

4.  5-Hydroxytryptamine antagonist ICS 205-930 blocks cardiac potassium, sodium and calcium currents.

Authors:  G Scholtysik; Y Imoto; A Yatani; A M Brown
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

5.  Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor.

Authors:  C M Villalón; M O den Boer; J P Heiligers; P R Saxena
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

6.  Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig.

Authors:  C M Villalón; M O den Boer; J P Heiligers; P R Saxena
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

Review 7.  Cardiovascular effects of serotonin agonists and antagonists.

Authors:  P R Saxena; C M Villalón
Journal:  J Cardiovasc Pharmacol       Date:  1990       Impact factor: 3.105

8.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

9.  5-Hydroxytryptamine-induced tachycardia in the pig: possible involvement of a new type of 5-hydroxytryptamine receptor.

Authors:  A H Bom; D J Duncker; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

10.  5-Hydroxytryptamine increases contractile force in porcine right atrium but not in left ventricle.

Authors:  R G Schoemaker; X Y Du; W A Bax; P R Saxena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

View more
  2 in total

1.  5-Hydroxytryptamine increases contractile force in porcine right atrium but not in left ventricle.

Authors:  R G Schoemaker; X Y Du; W A Bax; P R Saxena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

2.  Cardiac PDEs and crosstalk between cAMP and cGMP signalling pathways in the regulation of contractility.

Authors:  Finn Olav Levy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-05-07       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.